Baillie Gifford & Co’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-10,547,788
| Closed | -$482M | – | 207 |
|
|
2017
Q4 | $482M | Sell |
10,547,788
-300,612
| -3% | -$13.7M | 0.6% | 38 |
|
|
2017
Q3 | $487M | Sell |
10,848,400
-324,729
| -3% | -$14.6M | 0.62% | 36 |
|
|
2017
Q2 | $334M | Sell |
11,173,129
-24,734
| -0.2% | -$739K | 0.45% | 54 |
|
|
2017
Q1 | $248M | Buy |
11,197,863
+135,908
| +1% | +$3.02M | 0.36% | 61 |
|
|
2016
Q4 | $209M | Buy |
11,061,955
+213,104
| +2% | +$4.02M | 0.34% | 64 |
|
|
2016
Q3 | $326M | Buy |
10,848,851
+5,179
| +0% | +$155K | 0.51% | 50 |
|
|
2016
Q2 | $417M | Sell |
10,843,672
-74,705
| -0.7% | -$2.87M | 0.74% | 40 |
|
|
2016
Q1 | $416M | Buy |
10,918,377
+10,638,377
| +3,799% | +$405M | 0.73% | 36 |
|
|
2015
Q4 | $12.3M | Buy |
+280,000
| New | +$12.3M | 0.02% | 134 |
|